One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says

23rd April 2020 Uncategorised 0

Pharma companies are a popular target for politicians, activists and critics in general. But with the world in dire need of COVID-19 drugs and vaccines, the industry has a “once in a generation” opportunity to revamp its reputation, Eli Lilly CEO Dave Ricks said Thursday.

More: One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says
Source: fierce